Industri

Voro and Alloy partner on tumour-selective TCE therapeu...

The partnership will bring together Voro Therapeutics’ tumour-activated biologic...

DIA Medical Writing & Scientific Communications Confere...

Two-day conference to focus on regulatory writing, AI governance, patient-centri...

U.S. Department of Health and Human Services Announces ...

The U.S. Department of Health and Human Services has posted more than $700 milli...

LG AI Research and D&D Pharmatech sign agreement for or...

Executives from both organisations, including LG AI Research head Woohyung Lim a...

Jazz and AbCellera sign deal for T-cell engagers in sol...

The collaboration involves up to $56m in upfront payments to AbCellera for the f...

USFDA and EUDRA dashboards offer lessons for strengthen...

Milind Sathe analyses how public regulatory dashboards can support pharmaceutic...

We’re building for global markets, not just domestic scale

As the next-generation leader of the company, Nupur Shah, CEO of Cyano Pharma is...

Lupin launches Azilsartan Medoxomil tablets in the Unit...

Company receives US FDA approval and secures 180-day generic drug exclusivity fo...

Altaris to acquire Simulations Plus in $375m all-cash deal

Under the deal, Simulations Plus shareholders will receive $18.50 per share, rep...

AviadoBio broadens vMiX gene silencing licence with Kin...

The agreement broadens AviadoBio’s existing rights, which were previously limite...

From fintech to aesthetic injectables: Lessons in navig...

Rishi Agrawal, CEO, TeamLease RegTech cautions that the recent CDSCO clarificati...

Karnataka holds 64th Vision Group on Biotechnology meet...

Meeting discusses biotechnology strategy, AI integration, biomanufacturing and f...

Glenmark launches Methylene Blue Injection USP in US

Generic injectable approved as bioequivalent to ProvayBlue Injection 50 mg/10 mL

David Zambrana Elevated to President and CEO of Jackson...

On June 1, David Zambrana officially assumed the role of President and Chief Exe...

Chris Jann of Wold on Trends, Technology and the Evolut...

In April Wold Architects & Engineers announced Chris Jann as a Healthcare Busine...

ALK’s EURneffy secures MHRA approval for anaphylaxis tr...

This approval is said to be the first in the UK for a needle-free adrenaline tre...